Nevro Corp Price Earnings To Growth Ratio Over Time
| NVRO Stock | USD 3.77 0.02 0.53% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Nevro Corp Performance and Nevro Corp Correlation. Nevro |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.87) | Revenue Per Share 11.404 | Quarterly Revenue Growth (0.07) | Return On Assets (0.09) | Return On Equity (0.25) |
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price Earnings To Growth Ratio Analysis
Compare Nevro Corp and related stocks such as NuVasive, Integer Holdings Corp, and Glaukos Corp Price Earnings To Growth Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ITGR | 0.3316 | 1.602 | 1.602 | 1.602 | 1.602 | 1.602 | 0.0992 | 0.0992 | (0.5863) | (0.5863) | (2.1477) | 1.4585 | (1.1335) | 0.9566 | 1.0 |
| GKOS | 0.6487 | 0.6487 | 0.6487 | 0.6487 | 16.3378 | (0.0346) | (2.3436) | 94.0421 | (0.0112) | (0.6258) | 0.0367 | 0.6891 | (0.2192) | (0.866) | (0.82) |
| CNMD | (0.0106) | (9.8901) | 0.0037 | (3.6061) | (3.8269) | (6.6758) | (1.6162) | 0.0932 | (1.6283) | (3.6473) | (4.9958) | 0.1205 | 0.1467 | (0.2921) | (0.31) |
| LUNG | 1.9311 | 1.9311 | 1.9311 | 1.9311 | 1.9311 | 1.9311 | 1.9311 | 1.9311 | 1.9311 | 1.9311 | (1.3854) | (0.4762) | (0.2985) | (12.6529) | (12.02) |
| IRMD | 0.5083 | 0.5083 | 0.5083 | 0.5083 | 2.613 | 0.2093 | (11.3185) | (3.4852) | 0.05 | 0.4316 | (2.3193) | 0.1035 | 0.8098 | 1.0439 | 1.1 |
| OFIX | 2.3361 | 5.8448 | (0.0031) | 0.0959 | 0.932 | 3.893 | (1.0069) | 1.5925 | 0.5829 | 0.1018 | (3.0294) | 0.01 | 0.4191 | (0.0102) | (0.0097) |
| NPCE | 1.4132 | 1.4132 | 1.4132 | 1.4132 | 1.4132 | 1.4132 | 1.4132 | 1.4132 | 1.4132 | 1.4132 | 1.4132 | (1.9533) | (0.0176) | 0.195 | 0.2 |
| KIDS | 1.0185 | 1.0185 | 1.0185 | 1.0185 | 1.0185 | 1.0185 | 1.2818 | (0.0919) | 0.7577 | (1.7435) | (0.4169) | 1.3174 | (6.1057) | 0.0214 | 0.0225 |
| SGHT | (2.4225) | (2.4225) | (2.4225) | (2.4225) | (2.4225) | (2.4225) | (2.4225) | (2.4225) | (2.4225) | (2.4225) | (1.3072) | (0.1663) | (0.1917) | 0.1232 | 0.13 |
| CVRX | 9.7005 | 9.7005 | 9.7005 | 9.7005 | 9.7005 | 9.7005 | 9.7005 | 9.7005 | 9.7005 | 9.7005 | 9.7005 | (0.0306) | 2.1322 | 10.6644 | 11.2 |
| RXST | (0.1835) | (0.1835) | (0.1835) | (0.1835) | (0.1835) | (0.1835) | (0.1835) | (0.1835) | (0.1835) | (0.1835) | (0.1835) | 0.004 | (0.1483) | 0.6888 | 0.72 |
| FNA | (38.7606) | (38.7606) | (38.7606) | (38.7606) | (38.7606) | (38.7606) | (38.7606) | (38.7606) | (38.7606) | (38.7606) | (38.7606) | 0.1615 | (0.056) | 0.6256 | 0.66 |
| LIVN | (2.48) | (2.4344) | 1.4245 | 1.7087 | 1.7087 | 3.2184 | 0.2202 | 2.5712 | (0.0359) | 1.329 | (0.0786) | 0.5258 | 0.8629 | (1.32) | (1.25) |
| ELMD | 0.0526 | (1.0645) | 0.0089 | (0.0758) | (0.0758) | 0.1318 | (1.5784) | (1.5784) | 5.1286 | 0.2869 | (0.9306) | (9.9201) | 0.773 | 0.3785 | 0.4 |
| SRDX | 3.232 | (0.1971) | 0.2909 | (1.2709) | 1.2415 | (1.5517) | (1.7015) | 1.0117 | (0.3014) | (5.4947) | 0.6594 | 0.0212 | 3.1056 | (0.0737) | (0.0774) |
Nevro Corp and related stocks such as NuVasive, Integer Holdings Corp, and Glaukos Corp Price Earnings To Growth Ratio description
My Equities
My Current Equities and Potential Positions
| Nevro Corp | NVRO |
| Classification | Obamacare Repeal |
| Location | California; U.S.A |
| Exchange | New York Stock Exchange |
USD 3.77
Check out Nevro Corp Performance and Nevro Corp Correlation. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Nevro Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.